Cargando…

Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women

We aimed to identify how additional information about benefits and harms of cervical cancer (CC) screening impacted intention to participate in screening, what type of information on harms women preferred receiving, from whom, and whether it differed between two national healthcare settings. We cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cyr, P.R., Pedersen, K., Iyer, A.L., Bundorf, M.K., Goldhaber-Fiebert, J.D., Gyrd-Hansen, D., Kristiansen, I.S., Burger, E.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242055/ https://www.ncbi.nlm.nih.gov/pubmed/34221852 http://dx.doi.org/10.1016/j.pmedr.2021.101452

Ejemplares similares

Does the primary screening test influence women’s anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women
por: Burger, Emily A, et al.
Publicado: (2014)

Sun Exposure in Children: Balancing the Benefits and Harms
por: Jindal, Ankur K., et al.
Publicado: (2020)

A tool to balance benefit and harm when deciding about adjuvant therapy
por: Knops, A M, et al.
Publicado: (2009)

Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67
por: Desser, Arna S, et al.
Publicado: (2010)

Balancing the benefits and harms of radiotherapy post-radical prostatectomy
por: Lamb, Benjamin W., et al.
Publicado: (2018)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

ChatGPT and mental healthcare: balancing benefits with risks of harms
por: Blease, Charlotte, et al.
Publicado: (2023)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
por: Aschmann, Hélène E, et al.
Publicado: (2019)

Long-term antibiotics in COPD: more benefit than harm?
por: Miravitlles, Marc
Publicado: (2013)

Quantifying demographic and socioeconomic transitions for computational epidemiology: an open-source modeling approach applied to India
por: Basu, Sanjay, et al.
Publicado: (2015)

Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
por: Lindley, Richard I
Publicado: (2021)

Estimating the cost of cervical cancer screening in five developing countries
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2006)

Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
por: Cipriano, Lauren E., et al.
Publicado: (2018)

Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2023)

Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians
por: Mohan, V., et al.
Publicado: (2011)

Balancing harms and benefits of service mammography screening programs: a cohort study
por: Puliti, Donella, et al.
Publicado: (2012)

Block & replacement regimen is more cost effective than titration regimen in treating thyrotoxicosis in children, without more harm
por: Kwok, MK Anne, et al.
Publicado: (2015)

Balancing benefits and harm: Chemical use and bodily transformation among Indonesia's transgender waria
por: Idrus, Nurul Ilmi, et al.
Publicado: (2014)

What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
por: Bradley, Stephen H, et al.
Publicado: (2021)

Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic
por: Suen, Sze-chuan, et al.
Publicado: (2014)

Tuberculosis treatment discontinuation and symptom persistence: an observational study of Bihar, India’s public care system covering >100,000,000 inhabitants
por: Babiarz, Kimberly S, et al.
Publicado: (2014)

Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997
por: Chen, Brian K, et al.
Publicado: (2011)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Patterns of heavy drinking behaviour over age and birth cohorts among Chinese men: a Markov model
por: Lee, Kyueun, et al.
Publicado: (2021)

Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis
por: Bernard, Cora L., et al.
Publicado: (2017)

Diabetes, Its Treatment, and Catastrophic Medical Spending in 35 Developing Countries
por: Smith-Spangler, Crystal M., et al.
Publicado: (2012)

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
por: Liu, Shan, et al.
Publicado: (2011)

Mapping Inequality in SARS-CoV-2 Household Exposure and Transmission Risk in the USA
por: Reitsma, Marissa B., et al.
Publicado: (2021)

Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity
por: Reitsma, Marissa B., et al.
Publicado: (2021)

Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)

Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis
por: Claypool, Anneke L., et al.
Publicado: (2021)

Balance control mechanisms do not benefit from successive stimulation of different sensory systems
por: Cyr, Jean-Philippe, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013)

Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India
por: Mohanan, Manoj, et al.
Publicado: (2016)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

TRIOLOGY ACS: No benefit/No harm
por: Elmahdy, Mahmoud Farouk, et al.
Publicado: (2013)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

On harm thresholds and living organ donation: must the living donor benefit, on balance, from his donation?
por: Williams, Nicola Jane
Publicado: (2017)

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
por: Yebyo, Henock G., et al.
Publicado: (2019)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
por: Aronson, Jeffrey K.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gse5otpa25ra8jbfiip88jnea4